Stay updated on Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.

Latest updates to the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision label updated from v3.6.5 to v3.6.6, a minor version bump. No study content, outcomes, or eligibility details are altered by this change.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a small software or template update rather than substantive content changes.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s revision value changed from v3.6.3 to v3.6.4, signaling a deployment or maintenance update.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, signaling a minor update to the platform/template used for the study detail page. The change does not modify the study content or displayed data.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now shows Revision: v3.6.2, representing a minor update to the page's revision history.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page now includes new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and adds Last verified and Last known status was labels; it also shows a revision tag indicating a version update (v3.6.0) rather than changes to study content.SummaryDifference2%

Stay in the know with updates to Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.